ASX:EMV EMVision Medical Devices (EMV) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About EMVision Medical Devices Stock (ASX:EMV) 30 days 90 days 365 days Advanced Chart Remove Ads Get EMV alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume192,157 shsAverage VolumeN/AMarket Capitalization$165.05 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewEMVision Medical Devices Ltd engages in the research, development, and commercialization of imaging and diagnostic technology products. It develops a portable brain scanner for stroke diagnosis and monitoring, as well as other medical imaging needs. The company was incorporated in 2017 and is based in Macquarie Park, Australia.Read More… Remove Ads Receive EMV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for EMVision Medical Devices and its competitors with MarketBeat's FREE daily newsletter. Email Address EMV Stock News HeadlinesEMVision Reports Increased Losses Amid Ongoing R&D InvestmentsFebruary 27, 2025 | tipranks.comEMVision Medical Devices And 2 Other Promising Penny Stocks On The ASXFebruary 16, 2025 | finance.yahoo.comYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your free gift, and see how Trump's victory could spark major gains for gold.March 14, 2025 | American Alternative (Ad)EMVision Advances Neurodiagnostic Technology with Key Clinical Trials and InnovationsJanuary 27, 2025 | tipranks.comEMVision Secures $2.12M R&D Rebate from Australian GovernmentJanuary 19, 2025 | tipranks.comEMvision Medical Devices Ltd Ordinary Shares EMVDecember 13, 2024 | morningstar.comEMVision Showcases Innovative Scanners at ConferenceNovember 27, 2024 | tipranks.comEMvision’s Director Acquires 200,000 OptionsNovember 20, 2024 | markets.businessinsider.comSee More Headlines EMV Stock Analysis - Frequently Asked Questions How were EMVision Medical Devices' earnings last quarter? EMVision Medical Devices Ltd (ASX:EMV) issued its earnings results on Tuesday, February, 26th. The company reported ($4.47) EPS for the quarter. EMVision Medical Devices had a negative trailing twelve-month return on equity of 22.53% and a negative net margin of 24.33%. Company Calendar Last Earnings2/26/2019Today3/14/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolASX:EMV CIKN/A Webwww.emvision.com.au Phone61 2 8667 5337FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.03) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-2,730,000.00 Net Margins-24.33% Pretax MarginN/A Return on Equity-22.53% Return on Assets-7.95% Debt Debt-to-Equity Ratio15.66 Current Ratio6.40 Quick Ratio8.04 Sales & Book Value Annual Sales$11.22 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow8.47 Book ValueA$0.22 per share Price / BookN/AMiscellaneous Outstanding Shares85,520,000Free FloatN/AMarket Cap$165.05 million OptionableNot Optionable Beta1.47 7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (ASX:EMV) was last updated on 3/14/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredYour Wealth is Under AttackHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredElon’s desperate gambleWarning: "DOGE Collapse" Imminent After months of cost-cutting, controversy, and media buzz, DOGE is on the...Altimetry | SponsoredTrump’s new tariffs could break China’s grip on manufacturingLooming trade wars have China scrambling… Over 90% of global corporate executives said they are shutting do...Weiss Ratings | SponsoredIs 2025 really the best time to get rich in American history?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredMore important than tariffs for your stocksMost people are obsessed with Trump's on-again, off-again tariffs. Yes, the economic uncertainly is playin...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EMVision Medical Devices Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share EMVision Medical Devices With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.